ABOUT QIMING VENTURE PARTNERS
Founded in 2006, Qiming is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou and Hong Kong. In 2016, Qiming raised a US healthcare fund, and set up Qiming US office in Seattle. Currently Qiming manages five US Dollar funds and four RMB funds with US$2.7 billion assets under management.
ABOUT TF CAPITAL
TF Capital focuses on investment in the life sciences industry, primarily investing in early stage companies with high potential. Through strategic investments in various key areas and right partnerships, TF Capital hopes to capture opportunities in the rapidly expanding Chinese life sciences market. Our investment team has vast experience and resources in industry to assist our portfolio companies.
ABOUT HG CAPITAL
HG Healthcare Fund Management Co. Ltd., is a leading private equity fund management firm focused on the healthcare industry. Its fund I has over 1 billion RMB in assets under management. Fund II, which closed in May 2017 and raised over billions RMB, is focused on investing in mid-sized growth investments and buyouts in the healthcare sector. Investors (LP) of HG Healthcare Fund consist of 30+ healthcare public-listed companies.
Hangzhou Tigermed Consulting Co., Ltd（stock symbol: 300347） is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality.